SLP250 (R), n=1 cell(s)

Main group: Visual Projection Neurons; Neurotransmitter consensus prediction: unclear

Mean synapse counts per layer

  LA
Post -
Pre -
  M1 M2 M3 M4 M5 M6 M7 M8 M9 M10 Total
0 6.0 - 1.0 1.0 5.0 45.0 66.0 16.0 - - 140
1 - - - - - 5.0 16.0 - - - 21
  LO1 LO2 LO3 LO4 LO5a LO5b LO6 Total
Post - - - - - - 107.0 107.0
Pre - - - - - - - -
  AME
0 416
1 16
  LOP1 LOP2 LOP3 LOP4 Total
Post - - - - -
Pre - - - - -
  central brain
0 956
1 748

Neuron visualizations

Population spatial coverage

Medulla

Number of post synapses: 140

Number of pre synapses: 21

Number of output connections: 28

Coverage factor: 1.0

Columnar completeness: 0.04

Area completeness: 0.11

Cell size (columns): 40

Lobula

Number of post synapses: 107

Number of pre synapses: 0

Number of output connections: 0

Coverage factor: 1.0

Columnar completeness: 0.05

Area completeness: 0.32

Cell size (columns): 44

Lobula Plate

Number of post synapses: 0

Number of pre synapses: 0

Number of output connections: 0

Coverage factor: 0

Columnar completeness: 0

Area completeness: 0

Cell size (columns): 0

Optic Lobe Connectivity

Inputs

  instance NT total connections connections /#SLP250 (R) % % cumu.
0 aMe3 (R) Glu 136 136.0 14.9% 14.9%
1 MeLo1 (R) ACh 134 134.0 14.7% 29.6%
2 aMe1 (R) GABA 133 133.0 14.6% 44.2%
3 MeVPMe4 (L) Glu 34 34.0 3.7% 48.0%
4 HBeyelet (R) His 27 27.0 3.0% 50.9%
5 MeVPaMe2 (L) Glu 26 26.0 2.9% 53.8%
6 aMe2 (R) Glu 25 25.0 2.7% 56.5%
7 Mi10 (R) ACh 24 24.0 2.6% 59.2%
8 aMe6a (R) ACh 20 20.0 2.2% 61.4%
9 aMe12 (R) ACh 19 19.0 2.1% 63.4%
10 aMe5 (R) ACh 19 19.0 2.1% 65.5%
11 aMe6b (R) ACh 17 17.0 1.9% 67.4%
12 DNpe053 (R) ACh 15 15.0 1.6% 69.0%
13 MeTu4f (R) ACh 15 15.0 1.6% 70.7%
14 DNpe053 (L) ACh 14 14.0 1.5% 72.2%
15 MeVPMe11 (L) Glu 14 14.0 1.5% 73.8%
16 MeLo6 (R) ACh 10 10.0 1.1% 74.9%
17 aMe9 (R) ACh 8 8.0 0.9% 75.7%
18 MeVP1 (R) ACh 8 8.0 0.9% 76.6%
19 aMe4 (R) ACh 7 7.0 0.8% 77.4%
20 aMe9 (L) ACh 7 7.0 0.8% 78.2%
21 Cm17 (R) GABA 7 7.0 0.8% 78.9%
22 aMe26 (R) ACh 6 6.0 0.7% 79.6%
23 MeVC21 (R) Glu 6 6.0 0.7% 80.2%
24 OA-AL2i3 (R) OA 6 6.0 0.7% 80.9%
25 5thsLNv_LNd6 (R) ACh 5 5.0 0.5% 81.4%
26 Cm12 (R) GABA 5 5.0 0.5% 82.0%
27 LC41 (R) ACh 5 5.0 0.5% 82.5%
28 MeLo5 (R) ACh 5 5.0 0.5% 83.1%
29 MeTu1 (R) ACh 5 5.0 0.5% 83.6%
30 MeVC_unclear (R) Glu 5 5.0 0.5% 84.2%
31 MeVP45 (R) ACh 5 5.0 0.5% 84.7%
32 MeVP63 (R) GABA 5 5.0 0.5% 85.3%
33 MeVPMe6 (L) Glu 5 5.0 0.5% 85.8%
34 Tm38 (R) ACh 5 5.0 0.5% 86.4%
35 aMe12 (L) ACh 4 4.0 0.4% 86.8%
36 aMe30 (R) Glu 4 4.0 0.4% 87.3%
37 L3 (R) ACh 4 4.0 0.4% 87.7%
38 MeTu4c (R) ACh 4 4.0 0.4% 88.1%
39 MeVP7 (R) ACh 4 4.0 0.4% 88.6%
40 Cm24 (R) Glu 3 3.0 0.3% 88.9%
41 Cm30 (R) GABA 3 3.0 0.3% 89.2%
42 LoVP46 (R) Glu 3 3.0 0.3% 89.6%
43 LoVP62 (R) ACh 3 3.0 0.3% 89.9%
44 MeLo7 (R) ACh 3 3.0 0.3% 90.2%
45 MeVC22 (R) Glu 3 3.0 0.3% 90.6%
46 MeVC23 (R) Glu 3 3.0 0.3% 90.9%
47 MeVP12 (R) ACh 3 3.0 0.3% 91.2%
48 MeVP14 (R) ACh 3 3.0 0.3% 91.5%
49 MeVP52 (R) ACh 3 3.0 0.3% 91.9%
50 aMe10 (L) ACh 2 2.0 0.2% 92.1%
51 aMe17c (R) Glu 2 2.0 0.2% 92.3%
52 Cm21 (R) GABA 2 2.0 0.2% 92.5%
53 Cm31b (R) GABA 2 2.0 0.2% 92.8%
54 LC36 (R) ACh 2 2.0 0.2% 93.0%
55 Li30 (R) GABA 2 2.0 0.2% 93.2%
56 Li34b (R) GABA 2 2.0 0.2% 93.4%
57 LoVC19 (R) ACh 2 2.0 0.2% 93.6%
58 LoVCLo3 (R) OA 2 2.0 0.2% 93.9%
59 MeLo8 (R) GABA 2 2.0 0.2% 94.1%
60 MeVC2 (L) ACh 2 2.0 0.2% 94.3%
61 MeVCMe1 (R) ACh 2 2.0 0.2% 94.5%
62 MeVPMe3 (L) Glu 2 2.0 0.2% 94.7%
63 5-HTPMPV03 (L) 5HT 1 1.0 0.1% 94.8%
64 aMe10 (R) ACh 1 1.0 0.1% 95.0%
65 aMe17e (R) Glu 1 1.0 0.1% 95.1%
66 aMe22 (R) Glu 1 1.0 0.1% 95.2%
67 aMe8 (R) ACh 1 1.0 0.1% 95.3%
68 Cm11a (R) ACh 1 1.0 0.1% 95.4%
69 Cm26 (R) Glu 1 1.0 0.1% 95.5%
70 Cm28 (R) unclear 1 1.0 0.1% 95.6%
71 Cm32 (R) GABA 1 1.0 0.1% 95.7%
72 Dm2 (R) ACh 1 1.0 0.1% 95.8%
73 DN1a (R) unclear 1 1.0 0.1% 95.9%
74 DNp27 (R) unclear 1 1.0 0.1% 96.0%
75 Lawf1 (R) ACh 1 1.0 0.1% 96.2%
76 LC13 (R) ACh 1 1.0 0.1% 96.3%
77 LC46b (R) ACh 1 1.0 0.1% 96.4%
78 Li18b (R) GABA 1 1.0 0.1% 96.5%
79 Li39 (L) GABA 1 1.0 0.1% 96.6%
80 LoVC18 (R) Dop 1 1.0 0.1% 96.7%
81 LoVC20 (L) GABA 1 1.0 0.1% 96.8%
82 LoVC23 (L) GABA 1 1.0 0.1% 96.9%
83 LoVC25 (L) ACh 1 1.0 0.1% 97.0%
84 LoVCLo3 (L) OA 1 1.0 0.1% 97.1%
85 LoVP14 (R) ACh 1 1.0 0.1% 97.3%
86 LoVP43 (R) unclear 1 1.0 0.1% 97.4%
87 LoVP73 (R) unclear 1 1.0 0.1% 97.5%
88 LoVP96 (R) Glu 1 1.0 0.1% 97.6%
89 LPLC2 (R) ACh 1 1.0 0.1% 97.7%
90 LT55 (L) Glu 1 1.0 0.1% 97.8%
91 LT58 (R) Glu 1 1.0 0.1% 97.9%
92 LT70 (R) GABA 1 1.0 0.1% 98.0%
93 MeLo14 (R) Glu 1 1.0 0.1% 98.1%
94 MeLo2 (R) ACh 1 1.0 0.1% 98.2%
95 MeLo3a (R) ACh 1 1.0 0.1% 98.4%
96 MeLo3b (R) ACh 1 1.0 0.1% 98.5%
97 MeVCMe1 (L) ACh 1 1.0 0.1% 98.6%
98 MeVP10 (R) ACh 1 1.0 0.1% 98.7%
99 MeVP29 (R) ACh 1 1.0 0.1% 98.8%
100 MeVP3 (R) ACh 1 1.0 0.1% 98.9%
101 MeVP31 (R) ACh 1 1.0 0.1% 99.0%
102 MeVP42 (R) ACh 1 1.0 0.1% 99.1%
103 MeVP48 (R) unclear 1 1.0 0.1% 99.2%
104 MeVP9 (R) ACh 1 1.0 0.1% 99.3%
105 MeVPLo2 (L) ACh 1 1.0 0.1% 99.5%
106 MeVPLo2 (R) ACh 1 1.0 0.1% 99.6%
107 PLP211 (R) unclear 1 1.0 0.1% 99.7%
108 Pm13 (R) Glu 1 1.0 0.1% 99.8%
109 Tm16 (R) ACh 1 1.0 0.1% 99.9%
110 TmY10 (R) ACh 1 1.0 0.1% 100.0%

Outputs

  instance NT total connections connections /#SLP250 (R) % % cumu.
0 aMe10 (R) ACh 33 33.0 33.3% 33.3%
1 aMe1 (R) GABA 24 24.0 24.2% 57.6%
2 Cm35 (R) GABA 7 7.0 7.1% 64.6%
3 aMe5 (R) ACh 5 5.0 5.1% 69.7%
4 aMe17b (R) GABA 3 3.0 3.0% 72.7%
5 MeVP1 (R) ACh 3 3.0 3.0% 75.8%
6 Cm5 (R) GABA 2 2.0 2.0% 77.8%
7 Lat2 (R) unclear 2 2.0 2.0% 79.8%
8 Pm12 (R) Glu 2 2.0 2.0% 81.8%
9 TmY10 (R) ACh 2 2.0 2.0% 83.8%
10 aMe12 (R) ACh 1 1.0 1.0% 84.8%
11 aMe2 (R) Glu 1 1.0 1.0% 85.9%
12 Cm12 (R) GABA 1 1.0 1.0% 86.9%
13 Cm17 (R) GABA 1 1.0 1.0% 87.9%
14 Cm3 (R) GABA 1 1.0 1.0% 88.9%
15 Cm30 (R) GABA 1 1.0 1.0% 89.9%
16 Cm9 (R) Glu 1 1.0 1.0% 90.9%
17 LC10c-1 (R) ACh 1 1.0 1.0% 91.9%
18 LC12 (R) unclear 1 1.0 1.0% 92.9%
19 LT55 (R) Glu 1 1.0 1.0% 93.9%
20 MeLo1 (R) ACh 1 1.0 1.0% 94.9%
21 MeVC10 (L) ACh 1 1.0 1.0% 96.0%
22 MeVC22 (R) Glu 1 1.0 1.0% 97.0%
23 MeVC_unclear (R) Glu 1 1.0 1.0% 98.0%
24 MeVP42 (R) ACh 1 1.0 1.0% 99.0%
25 MeVPMe4 (L) Glu 1 1.0 1.0% 100.0%